Company Filing History:
Years Active: 2003
Title: William A. Schmalhofer: Innovator in Potassium Channel Inhibitors
Introduction
William A. Schmalhofer is a notable inventor based in South Plainfield, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target potassium channels. His work is essential for advancing treatments for various medical conditions.
Latest Patents
William A. Schmalhofer holds a patent for "Carbocyclic potassium channel inhibitors." This invention relates to a class of carbocyclic compounds of Formula I that are useful as potassium channel inhibitors. These compounds have potential applications in treating autoimmune disorders, cardiac arrhythmias, and similar health issues.
Career Highlights
Schmalhofer is currently associated with Merck & Company, Inc., a leading global healthcare company. His role at Merck allows him to work on innovative solutions that address critical health challenges. His expertise in medicinal chemistry and pharmacology has been instrumental in his career.
Collaborations
Some of his notable coworkers include Robert K. Baker and Jianming Bao. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
William A. Schmalhofer's work in potassium channel inhibitors exemplifies the impact of innovation in medicine. His contributions are paving the way for new treatments that can improve patient outcomes.